Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Application of Metabolomics for Translational and Biological Research (R21)
Release Date: January 17, 2007
Announcement Number: PA-07-302
Application Receipt Date:
February 16, 2007
June 16, 2007
October 16, 2007
February 16, 2008
June 16, 2008
October 16, 2008
February 16, 2009
June 16, 2009
October 16, 2009
Funding Contact: Danilo Tagle, Ph.D.
Program Area: Neurogenetics
Brief Description:
The purpose of this Funding Opportunity Announcement (FOA), sponsored by multiple NIH Institutes/Centers (ICs), is to promote
the use of metabolomic technologies in translational research in human health and disease for the purposes of enabling and
improving disease detection, diagnosis, risk assessment, prognosis, and prediction of therapeutic responses. In addition to
this overall goal, specific scopes and objectives of the participating ICs are presented below. Since this FOA uses the R21
funding mechanism, studies proposed are intended to be exploratory and may not achieve the status of complete validation.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |